Skip to main content
. 2022 Jun 6;28(5):702–712. doi: 10.1111/hae.14595

FIGURE 1.

FIGURE 1

Mechanism by which befovacimab inhibits TFPI and consequently allows thrombin production. FVa, factor Va; FXa, factor Xa; FVIIa, factor VIIa; TF, tissue factor; TFPI, tissue factor pathway inhibitor